{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T09:56:21Z","timestamp":1785232581174,"version":"3.55.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008725","name":"Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2015\/17\/D\/NZ4\/02284"],"award-info":[{"award-number":["2015\/17\/D\/NZ4\/02284"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.taap.2023.116382","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T15:10:42Z","timestamp":1674054642000},"page":"116382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Effect of pharmacological modulation of the kynurenine pathway on pain-related behavior and opioid analgesia in a mouse model of neuropathic pain"],"prefix":"10.1016","volume":"461","author":[{"given":"Katarzyna","family":"Ciapa\u0142a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Ciechanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Mika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Rojewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2023.116382_bb0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.117.014399","article-title":"Etiology and pharmacology of neuropathic pain","volume":"70","author":"Alles","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.taap.2023.116382_bb0010","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1471-4159.2009.05893.x","article-title":"On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo","volume":"109","author":"Amori","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2023.116382_bb0015","doi-asserted-by":"crossref","DOI":"10.1177\/1178646917691938","article-title":"Kynurenine pathway of tryptophan metabolism: Regulatory and functional aspects","author":"Badawy","year":"2017","journal-title":"Int. J. Tryptophan Res"},{"key":"10.1016\/j.taap.2023.116382_bb0020","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ics.2007.07.020","article-title":"Tryptophan metabolites as potent inhibitors of aldehyde dehydrogenase activity and potential alcoholism-aversion therapeutic agents","volume":"1304","author":"Badawy","year":"2007","journal-title":"Int. Congr. Ser."},{"key":"10.1016\/j.taap.2023.116382_bb0025","article-title":"Pain and immunity: implications for host defence","volume":"1","author":"Baral","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.taap.2023.116382_bb0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.taap.2023.116382_bb0035","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1021\/jm061015w","article-title":"Miniperspectives\u00a0: recent approaches in the treatment of neuropathic pain","volume":"50","author":"Butera","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.taap.2023.116382_bb0040","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.1523\/JNEUROSCI.2980-05.2005","article-title":"Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer\u2019s disease","volume":"25","author":"Chin","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.taap.2023.116382_bb0045","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nprot.2006.83","article-title":"The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on","volume":"1","author":"Chomczynski","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.taap.2023.116382_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011055","article-title":"The kynurenine pathway as a potential target for neuropathic pain therapy design: from basic research to clinical perspectives","volume":"22","author":"Ciapa\u0142a","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2023.116382_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/j.1526-4637.2010.00981.x","article-title":"NMDA receptor antagonists for the treatment of neuropathic pain","author":"Collins","year":"2010","journal-title":"Pain Med."},{"key":"10.1016\/j.taap.2023.116382_bb0060","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.taap.2023.116382_bb0065","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.neuropharm.2010.11.014","article-title":"G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: studies on the antinociceptive effects of kynurenic acid and zaprinast","volume":"60","author":"Cosi","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2023.116382_bb0070","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4155\/fmc.14.35","article-title":"Inhibitors of quinolinic acid synthesis: new weapons in the study of neuroinflammatory diseases","volume":"6","author":"Costantino","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.taap.2023.116382_bb0075","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00004647-199907000-00007","article-title":"Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4- (nitrophenyl)thiazol-2YL]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia","volume":"19","author":"Cozzi","year":"1999","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.taap.2023.116382_bb0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s10194-016-0638-5","article-title":"Altered kynurenine pathway metabolites in serum of chronic migraine patients","volume":"17","author":"Curto","year":"2015","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.taap.2023.116382_bb0085","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00018-019-03047-y","article-title":"Presynaptic NMDA receptors control nociceptive transmission at the spinal cord level in neuropathic pain","volume":"76","author":"Deng","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.taap.2023.116382_bb0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/toxsci\/kfq024","article-title":"Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling","volume":"115","author":"DiNatale","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2023.116382_bb0095","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0169-409X(03)00101-7","article-title":"Spinal delivery of analgesics in experimental models of pain and analgesia","volume":"55","author":"Fairbanks","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.taap.2023.116382_bb0100","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2174\/157015911795596621","article-title":"Kynurenine metabolites and migraine: experimental studies and therapeutic perspectives","volume":"9","author":"Fejes","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.taap.2023.116382_bb0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nn.3295","article-title":"Morphine hyperalgesia gated through microglia-mediated disruption of neuronal cl-homeostasis","volume":"16","author":"Ferrini","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.taap.2023.116382_bb0110","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/978-3-540-79090-7_16","article-title":"Role of calcium in regulating primary sensory neuronal excitability","volume":"194","author":"Gover","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.taap.2023.116382_bb0115","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.taap.2023.116382_bb0120","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1124\/dmd.112.050401","article-title":"Induction of xenobiotic receptors, transporters, and drug metabolizing enzymes by oxycodone","volume":"41","author":"Hassan","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2023.116382_bb0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/phrs.1998.0362","article-title":"The analgesic effects of tryptophan and its metabolites in the rat","volume":"38","author":"Heyliger","year":"1998","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2023.116382_bb0130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.sjpain.2017.08.002","article-title":"Targeting cytokines for treatment of neuropathic pain","volume":"17","author":"Hung","year":"2017","journal-title":"Scand J Pain"},{"key":"10.1016\/j.taap.2023.116382_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2019.110797","article-title":"Kynurenine signaling through the aryl hydrocarbon receptor: implications for aging and healthspan","author":"Kaiser","year":"2020","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.taap.2023.116382_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.pain.2007.09.027","article-title":"How different is oxycodone from morphine?","author":"Kalso","year":"2007","journal-title":"Pain."},{"key":"10.1016\/j.taap.2023.116382_bb0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/diagnostics9030082","article-title":"The IDO metabolic trap hypothesis for the etiology of ME\/CFS","volume":"9","author":"Kashi","year":"2019","journal-title":"Diagnostics"},{"key":"10.1016\/j.taap.2023.116382_bb0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2006.07.012","article-title":"Interferon-\u03b3 down-regulates transcription of the \u03bc-opioid receptor gene in neuronal and immune cells","volume":"181","author":"Kraus","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.taap.2023.116382_bb0155","doi-asserted-by":"crossref","first-page":"9879","DOI":"10.3390\/ijms22189879","article-title":"The kynurenine pathway\u2014new linkage between innate and adaptive immunity in autoimmune endocrinopathies","volume":"22","author":"Krupa","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2023.116382_bb0160","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cyto.2019.03.007","article-title":"Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia","volume":"119","author":"Kwiatkowski","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.taap.2023.116382_bb0165","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.neuron.2015.05.033","article-title":"Reduction of neuropathic and inflammatory pain through inhibition of the tetrahydrobiopterin pathway","volume":"86","author":"Latremoliere","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.taap.2023.116382_bb0170","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jpain.2019.11.010","article-title":"IFN\u03b2 treatment inhibits nerve injury-induced mechanical allodynia and MAPK signaling by activating ISG15 in mouse spinal cord","volume":"21","author":"Liu","year":"2020","journal-title":"J. Pain"},{"key":"10.1016\/j.taap.2023.116382_bb0175","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/104024","article-title":"Quinolinic acid: An endogenous neurotoxin with multiple targets","author":"Lugo-Huitr\u00f3n","year":"2013","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"119","key":"10.1016\/j.taap.2023.116382_bb0180","first-page":"197","article-title":"The kynurenine system and immunoregulation","volume":"1192","author":"M\u00e1ndi","year":"2011","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.taap.2023.116382_bb0185","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1186\/s12885-020-07371-6","article-title":"1-methyl-D-tryptophan activates aryl hydrocarbon receptor, a pathway associated with bladder cancer progression","volume":"20","author":"Matheus","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.taap.2023.116382_bb0190","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1213\/ane.0b013e3181b21c5e","article-title":"The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model","volume":"109","author":"Mecs","year":"2009","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.taap.2023.116382_bb0195","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejphar.2007.01.013","article-title":"Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain","volume":"560","author":"Mika","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2023.116382_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104420","article-title":"Delta-opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic pain","volume":"9","author":"Mika","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2023.116382_bb0205","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3390\/cells10061548","article-title":"Neuroinflammation and the kynurenine pathway in CNS disease: molecular mechanisms and therapeutic implications","volume":"10","author":"Mithaiwala","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.taap.2023.116382_bb0210","series-title":"Advances in Experimental Medicine and Biology","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-4615-0135-0_15","article-title":"Studies on the neuroprotective action of kynurenine mono-oxygenase inhibitors in post-ischemic brain damage","author":"Moroni","year":"2003"},{"key":"10.1016\/j.taap.2023.116382_bb0215","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.taap.2017.03.012","article-title":"Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor","volume":"323","author":"Moyer","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2023.116382_bb0220","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1476-5381.2012.02139.x","article-title":"Differential activation of the \u03bc-opioid receptor by oxycodone and morphine in pain-related brain regions in a bone cancer pain model","volume":"168","author":"Nakamura","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2023.116382_bb0225","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1567202054368326","article-title":"Role of kynurenines in the central and peripheral nervous systems","volume":"2","author":"N\u00e9meth","year":"2005","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.taap.2023.116382_bb0230","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1124\/mol.116.107367","article-title":"Buprenorphine, norbuprenorphine, R-methadone, and S-methadone upregulate BCRP\/ABCG2 expression by activating aryl hydrocarbon receptor in human placental trophoblasts","volume":"91","author":"Neradugomma","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2023.116382_bb0235","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1124\/mol.116.105361","article-title":"An aryl hydrocarbon receptor-mediated amplification loop that enforces cell migration in ER-\/PR-\/Her2- human breast cancer cells","volume":"90","author":"Novikov","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2023.116382_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019823","article-title":"The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-d-tryptophan upregulates IDO1 in human cancer cells","volume":"6","author":"Opitz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2023.116382_bb0245","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.taap.2023.116382_bb0250","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.3389\/fimmu.2021.781310","article-title":"Blockade of CC chemokine receptor type 3 diminishes pain and enhances opioid analgesic potency in a model of neuropathic pain","volume":"12","author":"Pawlik","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.taap.2023.116382_bb0255","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/j.1532-2149.2013.00305.x","article-title":"The l -kynurenine-probenecid combination reduces neuropathic pain in rats","volume":"17","author":"Pineda-Farias","year":"2013","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.taap.2023.116382_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/762930","article-title":"Minocycline enhances the effectiveness of nociceptin\/orphanin FQ during neuropathic pain","volume":"2014","author":"Popiolek-Barczyk","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.taap.2023.116382_bb0265","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1124\/jpet.103.060582","article-title":"Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain","volume":"309","author":"Rashid","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2023.116382_bb0270","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuropharm.2016.04.038","article-title":"Kynurenic acid and zaprinast induce analgesia by modulating HCN channels through GPR35 activation","volume":"108","author":"Resta","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2023.116382_bb0275","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8069-10-47","article-title":"Expression profiling of genes modulated by minocycline in a rat model of neuropathic pain","volume":"10","author":"Rojewska","year":"2014","journal-title":"Mol. Pain"},{"key":"10.1016\/j.taap.2023.116382_bb0280","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuropharm.2015.10.040","article-title":"Pharmacological kynurenine 3-monooxygenase enzyme inhibition significantly reduces neuropathic pain in a rat model","volume":"102","author":"Rojewska","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2023.116382_bb0285","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3389\/fphar.2018.00724","article-title":"Pharmacological inhibition of Indoleamine 2,3-Dioxygenase-2 and kynurenine 3-monooxygenase, enzymes of the kynurenine pathway, significantly diminishes neuropathic pain in a rat model","volume":"9","author":"Rojewska","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2023.116382_bb0290","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuroscience.2018.08.013","article-title":"Alterations in the activity of spinal and thalamic opioid Systems in a Mice Neuropathic Pain Model","volume":"390","author":"Rojewska","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.taap.2023.116382_bb0295","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pharep.2018.10.002","article-title":"Kynurenic acid and zaprinast diminished CXCL17-evoked pain-related behaviour and enhanced morphine analgesia in a mouse neuropathic pain model","volume":"71","author":"Rojewska","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.taap.2023.116382_bb0300","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1111\/j.1471-4159.1993.tb07443.x","article-title":"Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation","volume":"61","author":"Saito","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2023.116382_bb0305","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-019-0414-4","article-title":"The kynurenine pathway: a finger in every pie","author":"Savitz","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.taap.2023.116382_bb0310","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","article-title":"The kynurenine pathway and the brain: challenges, controversies and promises","volume":"112","author":"Schwarcz","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2023.116382_bb0315","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1073\/pnas.85.11.4079","article-title":"3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims","volume":"85","author":"Schwarcz","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2023.116382_bb0320","series-title":"The Laboratory Mouse","first-page":"527","article-title":"Routes of administration","author":"Shimizu","year":"2004"},{"key":"10.1016\/j.taap.2023.116382_bb0325","first-page":"45","article-title":"Neuropharmacology of quinolinic and kynurenic acids","author":"Stone","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.taap.2023.116382_bb0330","article-title":"Administration of substances to laboratory animals: Routes of administration and factors to consider","author":"Turner","year":"2011","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"10.1016\/j.taap.2023.116382_bb0335","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/00001756-200004270-00038","article-title":"Neuroprotective potency of kynurenic acid against excitotoxicity","volume":"11","author":"Urenjak","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.taap.2023.116382_bb0340","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2009.02.326","article-title":"The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection","volume":"283","author":"Vamos","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.taap.2023.116382_bb0345","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"van Hecke","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.taap.2023.116382_bb0350","doi-asserted-by":"crossref","first-page":"22021","DOI":"10.1074\/jbc.M603503200","article-title":"Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2023.116382_bb0355","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbi.2006.10.011","article-title":"Glia as the \u201cbad guys\u201d: implications for improving clinical pain control and the clinical utility of opioids","volume":"21","author":"Watkins","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.taap.2023.116382_bb0360","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fimmu.2020.00313","article-title":"The immunomodulator 1-methyltryptophan drives tryptophan catabolism toward the Kynurenic acid branch","volume":"11","author":"Wirthgen","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.taap.2023.116382_bb0365","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archgenpsychiatry.2011.71","article-title":"Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes","volume":"68","author":"Wonodi","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.taap.2023.116382_bb0370","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s11011-016-9824-z","article-title":"TDO as a therapeutic target in brain diseases","volume":"31","author":"Yu","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.taap.2023.116382_bb0375","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1586\/ecp.11.17","article-title":"Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain","volume":"4","author":"Zhou","year":"2011","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2023.116382_bb0380","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bbi.2015.01.013","article-title":"Peripheral indoleamine 2,3-dioxygenase 1 is required for comorbid depression-like behavior but does not contribute to neuropathic pain in mice","volume":"46","author":"Zhou","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.taap.2023.116382_bb0385","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X23000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X23000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:05:34Z","timestamp":1778659534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X23000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":77,"alternative-id":["S0041008X23000200"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2023.116382","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of pharmacological modulation of the kynurenine pathway on pain-related behavior and opioid analgesia in a mouse model of neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2023.116382","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116382"}}